FYI from the NHLBI Index

 

September 2011: Vol. 12, Issue 2
Research and Resources


NHLBI Research Initiatives

  • Sleep and Social Environment: Basic Biopsychosocial Processes (R21)
  • Effects of Secondhand Smoke on Cardiovascular and Pulmonary Disease Mechanisms (R01)
  • Spatial Uncertainty: Data, Modeling, and Communication (R01)
  • New Technology for Proteomics and Glycomics (SBIR [R43/R44])
  • Research on Ethical Issues in Biomedical, Social, and Behavioral Research (R01 and R21)
  • Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (Parent T32 and T35)
  • Nutrition and Diet in the Causation, Prevention, and Management of Heart Failure (R21)
  • The Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R01 and R21)
  • Nanoscience and Nanotechnology in Biology and Medicine (R01 and R21)
  • Phase II Clinical Trials of Novel Therapies for Lung Diseases (UM1)
  • Basic Research in Calcific Aortic Valve Disease (R01)
  • Pulmonary Vascular-Right Ventricular Axis Research Program (R01)

Need More Information?


NHLBI Research Initiatives

From time to time, the NHLBI invites investigators to submit grant applications or contract proposals for specific research programs. We are soliciting applications for the new programs described below. Please visit the URL listed with each program to obtain information about application dates and deadlines. For full details of these and other current research initiatives, visit www.nhlbi.nih.gov/funding/inits/index.htm.


Sleep and Social Environment: Basic Biopsychosocial Processes (R21)

  • Initiative Number: RFA-HD-12-204
  • Objective: Investigate the interactions of sleep and circadian regulation and function with the behavioral and social environment.

Effects of Secondhand Smoke on Cardiovascular and Pulmonary Disease Mechanisms (R01)

  • Initiative Number: PA-11-244
  • Objective: Characterize the dose-response relationship between secondhand smoke exposure and cardiovascular and pulmonary diseases.

Spatial Uncertainty: Data, Modeling, and Communication (R01)

  • Initiative Number: PA-11-238 and PA-11-239
  • Objective: Identify sources of inaccuracy or instability of spatial or geographic information in public health data, adjust for the inaccuracy or instability in statistical methods, and develop novel tools to visualize the nature and consequences of spatial uncertainty.

New Technology for Proteomics and Glycomics (SBIR [R43/R44])

  • Initiative Number: PA-11-214 and PA-11-215
  • Objective: Develop broadly applicable research tools that address the core technical challenges in proteomics and glycomics.

Research on Ethical Issues in Biomedical, Social, and Behavioral Research (R01 and R21)

  • Initiative Number: PA-11-180 and PA-11-182
  • Objective: Study high-priority bioethical challenges and issues associated with biomedical, social, and behavioral research.

Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (Parent T32 and T35)

  • Initiative Number: PA-11-184 and PA-11-185
  • Objective: Enhance research training opportunities for predoctoral and postdoctoral level individuals interested in careers in biomedical, behavioral and clinical research.

Nutrition and Diet in the Causation, Prevention, and Management of Heart Failure (R21)

  • Initiative Number: PA-11-165 and PA-11-166
  • Objective: Develop nutritional management and preventive measures for patients in various stages of heart failure and for high-risk individuals.

The Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R01 and R21)

  • Initiative Number: PA-11-162 and PA-11-163
  • Objective: Improve the measurement of racial/ethnic discrimination in health-care delivery systems, enhance understanding of its influence, and reduce its prevalence in the United States.

Nanoscience and Nanotechnology in Biology and Medicine (R01 and R21)

  • Initiative Number: PA-11-148 and PA-11-149
  • Objective: Support cutting-edge nanoscience and nanotechnology research for the diagnosis, treatment, and management of an array of diseases and traumatic injuries.

Phase II Clinical Trials of Novel Therapies for Lung Diseases (UM1)

  • Initiative Number: RFA-HL-12-022
  • Objective: Test novel interventions that could change significantly the clinical management of a lung disease or a sleep-related cardiopulmonary disorder.

Basic Research in Calcific Aortic Valve Disease (R01)

  • Initiative Number: RFA-HL-12-015
  • Objective: Encourage innovative molecular and physiological research leading to early diagnosis or effective medical therapy for calcific aortic valve disease.

Pulmonary Vascular-Right Ventricular Axis Research Program (R01)

  • Initiative Number: RFA-HL-12-021
  • Objective: Study right ventricular function/dysfunction in order to improve diagnostics and therapeutics.







Need More Information?

We are always interested in receiving comments and suggestions from the community. If you or your organizations have questions for me or for the Institute, please contact me at shurinsb@nhlbi.nih.gov or Dr. Carl Roth at rothc@nhlbi.nih.gov.


Susan B. Shurin, M.D.
Acting Director, NHLBI

For information on specific issues, the following contacts may be helpful:

For health related questions and publications, please contact the trained information specialists at the NHLBI Information Center (NHLBIinfo@nhlbi.nih.gov) or write to the Information Center at P.O. Box 30105, Bethesda, MD 20824-0105.

For communications pertaining to NHLBI policies and priorities, contact the NHLBI Office of Public Liaison, (nhlbi.listens@nih.gov).

For additional information regarding NHLBI events, consult the references provided or NHLBI Calendar. Most other NIH Institutes and Centers also maintain calendars on their websites. Links to their Web pages are at NIH Institutes, Centers, and Offices.

For Web related matters pertaining to the online version of the FYI from the NHLBI, contact the FYI from the NHLBI's Web Editor.



Please send us your feedback, comments, and questions by using the appropriate link on the page, Contact the NHLBI.

Note to users of screen readers and other assistive technologies: please report your problems here.

Skip footer links and go to content
Twitter iconTwitterExternal link Disclaimer         Facebook iconFacebookimage of external link icon         YouTube iconYouTubeimage of external link icon         Google+ iconGoogle+image of external link icon